Metraipolis › archive › dc_288473fb6aee

Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein — Europe PMC PMID:35524344

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35524344
DOI
10.1111/bcp.15392
License (as archived)
solo-consultazione
Archived
2026-10-06T10:24:32.821Z
SHA-256 of the archived text
f19eb0f3e6921dae092d1b190ba2cf7183e1488dbeb39b2e0656af267393b209
Stable URL of this page
https://metraipolis.com/documento/dc_288473fb6aee

How to cite

Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein — Europe PMC PMID:35524344 — Europe PMC (en), https://europepmc.org/article/MED/35524344 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_288473fb6aee (Metraipolis archive dc_288473fb6aee, sha256 f19eb0f3e6921dae092d1b190ba2cf7183e1488dbeb39b2e0656af267393b209)
BibTeX
@misc{dc288473fb6aee,
  title = {Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein — Europe PMC PMID:35524344},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35524344},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_288473fb6aee; sha256 f19eb0f3e6921dae092d1b190ba2cf7183e1488dbeb39b2e0656af267393b209},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35524344. Agents can read the archived copy with the MCP tool read_document.